FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Leadiant Biosciences Cystaran Recall

Cystaran (cysteamine ophthalmic solution) 0

Leadiant Biosciences, Inc. · Gaithersburg, MD

Risk level
Class III
Reported by FDA
Oct 21, 2020
Recall ID
D-0034-2021
Check your lot numberHow we source this data

Summary

Leadiant Biosciences recalled Cystaran starting Sep 24, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0034-2021 on Oct 21, 2020. Reason: Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl. Status: Terminated.

Why it was recalled

Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.

Product description

Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, Rx Only, Manufactured by Hi-Tech Pharmacal Co Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01

Lot numbers, UPCs & expiration codes

Lot #: 370655, Exp. 10/31/2020

Where it was sold

PA and Italy

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0034-2021
Classification
Class III
Status
Terminated
Recall initiated
Sep 24, 2020
FDA report date
Oct 21, 2020
Quantity
1380 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Leadiant Biosciences, Inc.

Original FDA data

Every field from FDA enforcement report D-0034-2021, exactly as published.

Show all FDA fields
City
Gaithersburg
State
MD
Status
Terminated
Country
United States
Event ID
86525
Address
9841 Washingtonian Blvd Ste 500
Code information
Lot #: 370655, Exp. 10/31/2020
Postal code
20878-7352
Report date
Oct 21, 2020
Product type
Drugs
Recall number
D-0034-2021
Classification
Class III
Recalling firm
Leadiant Biosciences, Inc.
Product quantity
1380 bottles
Termination date
Nov 10, 2021
Reason for recall
Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, Rx Only, Manufactured by Hi-Tech Pharmacal Co Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01
Distribution pattern
PA and Italy
Recall initiation date
Sep 24, 2020
Initial firm notification
Letter
Center classification date
Oct 15, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0034-2021, published Oct 21, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls